Researchers studied outcomes from 45,912 patients who received kidneys from 35,851 deceased coronavirus-positive donors between March 1, 2020, and March 30, 2023.
“The use of kidneys from donors with active or resolved COVID-19 is safe, with excellent outcomes during medium-term follow-up,” they wrote of their findings.
Notably, there was no increase in the rejection rate or transplanted organs either. With an average wait time for a kidney being between three and five years in the U.S., the study highlights that donors should not be excluded due to past or present COVID-19 infection and doing so would “substantially limit opportunities for organ use and [kidney transplant], which is not a benign consequence,” researchers wrote.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.